Spruce BioSciences
IPOSouth San Francisco, United States · $88.0M raised
- Headquarters
- South San Francisco, California
- Employees
- 11–50
- Business Model
- B2B
- Website
- sprucebiosciences.com
- Total Funding
- $88.0M
- Last Round
- $88.0M Series BFeb 2020
- Rounds
- 2
About
Spruce BioSciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine and neurological disorders. Headquartered in South San Francisco, California, the company targets underserved patient populations with significant unmet medical needs.
Summary
Spruce BioSciences is a Biotech company based in South San Francisco, United States. It has raised $88.0M in total across 2 rounds, most recently a $88.0M Series B round in Feb 2020. Investors include Omega Funds, Abingworth Bioventures and Novo Holdings A/S.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2020
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...